Trial intelligence / Profile preview

Intrathecal baclofen pump versus selective dorsal rhizotomy for non-ambulatory children with cerebral palsy

2024-518822-33-01Phase 4Authorised

Sponsor
UZ Leuven
Start
Jan 2026
Modality
Small Molecules
Countries
2
01

Overview

Phase 4, randomised trial of baclofen in cerebral palsy (CP) (2 arms), sponsored by UZ Leuven. Planned start Jan 2026; status: authorised.

02

Drugs

baclofen
03

Conditions

cerebral palsy (CP)

Beyond the preview

Go deeper on 2024-518822-33-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518822-33-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call